bioRxiv Science⌕ Search

bioRxiv · 10.1101/550236

Prolonged Ocular Exposure Leads to the Formation of Retinal Lesions in Mice

Abstract

The observation of retinal lesions in the posterior pole of laboratory mice has been found to occur for many reasons, some of which are due to native, developmental abnormalities and those that are influenced by environmental or experimental conditions. Herein, we investigated the rate and extent of retinal lesions as a result of prolonged ocular exposure following general anesthesia. Mice were housed under standard animal care conditions and transported to the laboratory for experimental preparation induction procedures (EPIP) involving general anesthesia, mydriasis/cycloplegia, and topical anesthesia to the cornea. Following EPIP, two ocular recovery conditions (protected and unprotected) were tested within two different animal recovery chambers (open or closed). During anesthesia recovery, and extending up to 2.5 months thereafter, the anterior and posterior poles were evaluated using digital color photography, scanning laser ophthalmoscopy, and spectral-domain optical coherence tomography to document the effects of eye protection and chamber recovery type on the development of retinal lesions. In some mice, electroretinograms and histological evaluations were performed to assess functional and structural changes that accompanied the retinal lesions detected by in vivo imaging. We found that the anterior segments of mice recovered in the open chamber with unprotected eyes showed substantial acute changes. At 1-hour post-EPIP, the anterior chamber exhibited corneal thinning, severe media opacities, a reduction in anterior chamber depth, and ocular lens prolapse. These changes largely resolved upon recovery. At 3- and 14-days post-EPIP, inspection of the posterior pole by fundus imaging revealed prominent lesions in the outer retina in a significant proportion of mice recovered in the open chamber. ERG testing conducted at 1-month post-EPIP revealed compromised functional responses in the eyes of affected vs. unaffected mice. Imaging at 14-days post-EPIP revealed that the outer retina lesions in affected mice almost wholly resolve over time to nearly insignificant levels. However, data collected at 80-days post-EPIP demonstrates that some lingering effects persist long-term and appear to be confined to the retinal pigment epithelium. In comparison, mice recovered in the closed chamber with unprotected eyes experienced only mild lens opacities at 1-hr post EPIP that cleared following a full recovery from the effects of sedation. Furthermore, protected eyes of mice recovered in either the open or closed chamber were completely devoid of any anterior or posterior pole complications. In sum, prolonged ocular surface exposure to circulating ambient room air leads to significant anterior and posterior segment ocular complications. We interpret these changes to be caused by dehydration and desiccation of the corneal surface of the eye. The most abundant, semi-reversible complication observed was the development of lesions in the outer retina, which had a 90% probability of occurring after 45 minutes of exposure. The lesions largely absolved short-term but some imaging evidence suggests that they may persist months after their initial appearance. DisclosuresB.A. Bell, none; V.L. Bonilha, none; S.A. Hagstrom, none; B.Anand-Apte, none; 14 J.G. Hollyfield, none; I.S. Samuels, none. Grant InformationResearch reported in this publication was supported by the National Eye Institute of the National Institutes of Health under award numbers P30EY025585, R01EY016490, RO1EY026181, RO1EY027083, R01EY014240 and R01EY027750, US Dept. of Veterans Affairs Biomedical Laboratory Research and Development Service VA Merit Award I01BX002754, an unrestricted grant from the Research to Prevent Blindness to the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Foundation for Fighting Blindness Research Center Grant, The Wolf Family Foundation, the Llura and Gordon Gund Foundation and the Cleveland Clinic. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the US Dept. of Veterans Affairs.

Source connections

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Bell, B. A., Bonilha, V., Hagstrom, S., Anand-Apte, B., Hollyfield, J. G., Samuels, I.. 2019-02-19. Prolonged Ocular Exposure Leads to the Formation of Retinal Lesions in Mice. https://doi.org/10.1101/550236

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Midlife nonlinearities across scale in Biondi body amyloid formation in the human choroid plexus

Human choroid plexus epithelial cells (CPECs), which produce cerebrospinal fluid and form the blood-cerebrospinal fluid barrier, accumulate discrete intracellular amyloid inclusions called Biondi bodies (BBs). Using systematic manual and machine learning approaches on the choroid plexus glomus, we determined the percentages of CPECs containing thioflavin S-stained BBs as well as BB load and spatial distributions in whole slide images from 77 cases across the human lifespan. On average, BB prevalence was near zero until age 40, rose steeply in the 5th and 6th decades, and exceeded 50% after age 70. As prevalence plateaued, BB load continued to rise with age. Accelerated BB accumulation was seen in two cases of diabetic ketoacidosis, including a 16-year-old, while an 85-year-old with the relatively rare APOE2/E2 genotype had fewer BBs than expected. BB prevalence in the choroid plexus glomus was not associated with Alzheimer's disease, but was lower in females than males. Notably, spatial clustering of BBs was universal across cases while nearest-neighbor analyses suggested cell-to-cell, prion-like BB spread that can account for the nonlinearities seen at tissue and population scales. The abrupt, nonlinear BB accumulation during midlife coincides with or precedes other common aging-associated neuropathologies of the human brain, consistent with broad BB and choroid plexus contributions to brain aging and disease.

pathology↗

Elevated precontractile calcium set point is sustained by limited PMCA1 export in dystrophic muscle

Duchenne muscular dystrophy is caused by loss of dystrophin and marked by elevated muscle calcium, usually attributed to contraction-induced membrane damage. Whether calcium rises before muscle can contract, and what sustains it, is unresolved. In Caenorhabditis elegans embryos and patient-derived human myoblasts, dystrophic muscle carries an elevated resting calcium set point before contraction is possible. Embryonic calcium is elevated 400 minutes after fertilization, before movement is detectable or the neuromuscular junction forms. Silencing the plasma membrane calcium pump gene mca-1 raises calcium in wild-type but not dystrophic animals, whereas silencing its paralogue raises it in both: the limitation is specific to that export route. Dystrophic human myoblasts have less pump; pump inhibition or silencing increases calcium preferentially in healthy cells, and raising pump expression lowers calcium most in dystrophic cells. Constrained calcium export is an early, continuing determinant of the dystrophic set point.

pathology↗

Systematic comparison of gliflozins identifies a selective anti-calcifying effect of canagliflozin beyond canonical SGLT2 inhibition

Background: Sodium-glucose cotransporter 2 inhibitors (SGLT2i) provide important cardiorenal benefits in chronic kidney disease (CKD), but their effects on vascular calcification remain conflicting. Whether potential anti-calcifying effects are shared across gliflozins or involve mechanisms beyond canonical SGLT2 inhibition is unknown. Methods: We systematically compared canagliflozin, dapagliflozin and empagliflozin in a high-phosphate diet-induced mouse model of vascular calcification and complementary ex vivo and in vitro models, including rodent and human vascular tissues and vascular smooth muscle cells (VSMCs). Aortic transcriptional response was investigated by RNA sequencing. VSMC calcification, proliferation, migration, viability, glucose uptake and bioenergetics were investigated using complementary cellular assays, including OsteoSense staining, Annexin V/propidium iodide staining, radiolabeled 2-deoxyglucose uptake and Seahorse ATP rate analysis. SGLT2/1 expression was examined by RT-qPCR, Western blotting and immunofluorescence. We also evaluated sotagliflozin, a dual SGLT1/2 inhibitor, and mizagliflozin, a selective SGLT1 inhibitor. Results: Among the three gliflozins, only canagliflozin significantly reduced aortic calcification in vivo. Its anti-calcifying effect was also observed in rodent aortic rings, human vascular explants, cultured VSMCs and aortic rings from diabetic db/db mice. Aortic RNA-seq revealed that canagliflozin partially reversed HPD-induced transcriptional alterations, including changes in pro-calcific signaling and cellular metabolism, while some endothelial and inflammatory responses were shared among gliflozins. In mouse VSMCs, canagliflozin reduced calcification across all tested concentrations, dose-dependently decreased osteogenic marker expression, and reduced proliferation and migration. Increased apoptotic and damaged cell fractions were observed at higher concentrations, but not at lower concentrations. Canagliflozin also reduced glucose uptake and mitochondrial ATP production, without significantly affecting glycolytic ATP production. Neither dapagliflozin nor empagliflozin reproduced these cellular and metabolic effects at any of the concentrations tested. SGLT2 and SGLT1 expression was low or undetectable in vascular tissues and cells, and neither sotagliflozin nor mizagliflozin reproduced the anti-calcifying effect of canagliflozin in vivo or in vitro. Conclusions: Canagliflozin exhibits a selective anti-calcifying profile among the gliflozins tested, associated with changes in VSMC responses and cellular metabolism. These findings suggest that its vascular protective effects may involve mechanisms beyond canonical SGLT2 inhibition.

pathology↗